Close Mobile Navigation

WELCOME TO THE
KEYTRUDA
PATIENT SUPPORT
WEBSITE


GET ACCESS

To access this website, you must be a current patient being treated with KEYTRUDA in Australia and be 18 years or older.

  • The access code is supplied within the KEYTRUDA patient booklet which you can request from your healthcare professional, if you don’t have a copy.
  • Alternatively, please contact your treating healthcare professional to request the access code to access this website.

Registered users are no longer required to sign in using their registered email address and password. Please enter the access code to continue accessing this website.

The access code entered is not valid, please try again or contact your Healthcare Professional.


MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.


WHO MAKES KEYTRUDA?


MSD

For more than 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

MSD is a trade name of Merck & Co., Inc., with headquarters in Rahway, N.J., U.S.A.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.msd-australia.com.au and connect with us on Twitter, LinkedIn and YouTube.




KEYTRUDA Australian Consumer Medicine Information www.msdinfo.com.au/keytrudacmi.

For further information about your condition or treatment consult your healthcare professional or refer to the Consumer Medicine Information for KEYTRUDA.

AU-KEY-00464. Issued September 2023.



MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.